Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
  1. 8-K Event Executive or director change
  2. SC 13G/A Stake Amended Statement of Ownership
  3. SC 13G/A Stake Amended Statement of Ownership
  4. 8-K Event Agreement ended
  5. 4 Open-market sale Director sold 4,835 shares at $161.86 ($782,579)
  6. 4 Open-market sale Chief Executive Officer sold 3,000 shares at $160.50 ($481,500)
  7. 4 Open-market sale President and COO sold 11,160 shares at $163.02 ($1,819,255)
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations
  10. SC 13G/A Stake Amended Statement of Ownership
  11. 8-K Event Other events
  12. 4 Open-market sale President and COO sold 8,840 shares at $109.67 ($969,507)
  13. 10-Q Report Quarterly Report
  14. 8-K Event Results of operations
  15. 8-K Event Other events
  16. 4 Grant or award Director acquired 1,161 shares (grant or award)
  17. 3 Insider Initial Statement of Ownership
  18. 8-K Event Executive or director change · Regulation FD disclosure · Other events
  19. 4 Other acquisition Chief Executive Officer acquired 247 shares (other)
  20. 4 Other acquisition EVP,Finance & Strategy and CFO acquired 247 shares (other)

Page 24 of 115 · 2,300 filings